Author:
Lejman M.,Drabko K.,Styka B.,Winnicka D.,Babicz M.,Jaszczuk I.,Kowalczyk J.R.
Reference31 articles.
1. Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a global observational study;Gratwohl;Haematologica,2013
2. McCann SR, Lawler M. The value of molecular monitoring in haematological malignancy; minimal residual diseases (MRD), relapse and chimeras. In: Apperley J, Carreras E, Gluckman E, et al., editors. The EBMT Handbook. Revised Edition13; Forum Service Editore 2008 EBMT and ESH, p.255–73.
3. Molecular monitoring after HSCT: Chimerism;Lion;The EBMT Handbook,2012
4. How and when should we monitor chimerism after allogenic stem cell transplantation?;Bader;Bone Marrow Transplant,2005
5. Strategies and clinical implications of chimerism diagnostics after allogeneic hematopoietic stem cell transplantation;Thiede;Acta Haematol,2004
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献